These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 761175)

  • 1. Combination chemotherapy in recurrent medulloblastoma.
    Duffner PK; Cohen ME; Thomas PR; Sinks LF; Freeman AI
    Cancer; 1979 Jan; 43(1):41-5. PubMed ID: 761175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality therapy for medulloblastoma.
    Thomas PR; Duffner PK; Cohen ME; Sinks LF; Tebbi C; Freeman AI
    Cancer; 1980 Feb; 45(4):666-9. PubMed ID: 6766791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in recurrent noncystic low-grade astrocytomas of the cerebrum in children.
    Sumer T; Freeman AI; Cohen M; Bremer AM; Thomas PR; Sinks LF
    J Surg Oncol; 1978; 10(1):45-54. PubMed ID: 628217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial BCNU in the treatment of recurrent medulloblastoma.
    Watne K; Hager B; Hirschberg H
    J Neurooncol; 1990 Apr; 8(2):139-43. PubMed ID: 2358848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trial of a systematic chemotherapy in medulloblastomas of the posterior fossa in children].
    Jundt S
    Neurochirurgie; 1974; 20(2):170-1. PubMed ID: 4479347
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to vincristine and Procarbazine of recurrent medulloblastomas. Report of 2 cases.
    Seiler RW; Reichenbach W; Fricker U; Wagner HP
    Helv Paediatr Acta; 1978 Jun; 33(2):177-81. PubMed ID: 659260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study.
    van Eys J; Chen T; Moore T; Cheek W; Sexauer C; Starling K
    Cancer Treat Rep; 1981; 65(7-8):681-4. PubMed ID: 7248985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy with MOPP and intrathecal methotrexate in children with brain tumors].
    Sato J; Ninomiya T; Saijo T; Akita H; Miki Y; Hirose M; Hashimoto T; Miyao M; Matsumoto K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3266-70. PubMed ID: 3777962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
    Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB
    J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
    Bessell EM; Graus F; Punt JA; Firth JL; Hope DT; Moloney AJ; Lopez-Guillermo A; Villa S
    J Clin Oncol; 1996 Mar; 14(3):945-54. PubMed ID: 8622044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB).
    Cohen IJ; Vogel R; Matz S; Weitz R; Mor C; Stern S; Zaizov R
    Cancer; 1986 Jan; 57(1):6-11. PubMed ID: 3940623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.
    Friedman HS; Mahaley MS; Schold SC; Vick NA; Falletta JM; Bullard DE; D'Souza BJ; Khandekar JD; Lew S; Oakes WJ
    Neurosurgery; 1986 Mar; 18(3):335-40. PubMed ID: 3703192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of primary malignant brain tumors in children.
    Shapiro WR
    Cancer; 1975 Mar; 35(3 suppl):965-72. PubMed ID: 1111955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report.
    Packer RJ; Siegel KR; Sutton LN; Evans AE; D'Angio G; Rorke LB; Bunin GR; Schut L
    Ann Neurol; 1988 Oct; 24(4):503-8. PubMed ID: 3239953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primitive neuroectodermal tumors of childhood. An approach to therapy.
    Duffner PK; Cohen ME; Heffner RR; Freeman AI
    J Neurosurg; 1981 Sep; 55(3):376-81. PubMed ID: 6267228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for medulloblastomas and primitive neuroectodermal tumors.
    Cohen BH; Packer RJ
    J Neurooncol; 1996 Jul; 29(1):55-68. PubMed ID: 8817416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma.
    Levin VA; Vestnys PS; Edwards MS; Wara WM; Fulton D; Barger G; Seager M; Wilson CB
    Cancer; 1983 Apr; 51(8):1364-70. PubMed ID: 6687443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.